GWAS 2020-09-07

Zhang H, Liu AP et al.

J Natl Cancer Inst

Minimal residual disease (MRD) after induction therapy is one of the strongest prognostic factors in...

End-of-induction therapy minimal residual disease in childhood acute lymphoblastic leukemia

Replicated

3088

Participants

N/A

Studies

Title

Author

Journal

Disease/Trait

Date

Actions

Zhang H, Liu AP et al.

J Natl Cancer Inst

End-of-induction therapy minimal residual disease in childhood acute lymphoblastic leukemia

2020-09-07